Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BHVN Biohaven Pharmaceutical Holding Co Ltd.

提前休市 12-24 13:00:00 EST

10.81

+0.31

+2.95%

盘后9.02

-1.79-16.56%

16:59 EST

最高10.82	最低10.46	成交量144.11万
今开10.56	昨收10.50	日振幅3.43%
总市值14.34亿	流通市值12.11亿	总股本1.33亿
成交额1,542万	换手率1.29%	流通股本1.12亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":10.81,"timestamp":1766599200000,"preClose":10.5,"halted":0,"volume":1441118,"hourTrading":{"tag":"盘后","latestPrice":9.02,"preClose":10.81,"latestTime":"16:59 EST","volume":233911,"amount":2131293.877249,"timestamp":1766613576729},"delay":0,"floatShares":112000000,"shares":132637000,"eps":-7.586766,"marketStatus":"提前休市","change":0.31,"latestTime":"12-24 13:00:00 EST","open":10.56,"high":10.82,"low":10.46,"amount":15420161.474284,"amplitude":0.034286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.586766,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":6,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":10.5,"preHourTrading":{"tag":"盘前","latestPrice":10.7,"preClose":10.5,"latestTime":"09:13 EST","volume":218,"amount":2292.8913,"timestamp":1766585624618},"postHourTrading":{"tag":"盘后","latestPrice":9.02,"preClose":10.81,"latestTime":"16:59 EST","volume":233911,"amount":2131293.877249,"timestamp":1766613576729},"volumeRatio":0.814647,"impliedVol":1.3614,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/BHVN","defaultTab":"news","newsList":[{"id":"1100042719","title":"Biohaven 更新Bhv-7000在重度抑郁症的第二阶段概念验证研究进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100042719","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100042719?lang=zh_cn&edition=full","pubTime":"2025-12-25 02:01","pubTimestamp":1766599271,"startTime":"0","endTime":"0","summary":"Biohaven 更新Bhv-7000在重度抑郁症的第二阶段概念验证研究进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BK4139","BHVN","LU1093756168.USD"],"gpt_icon":0},{"id":"2587632557","title":"Biohaven Ltd.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587632557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587632557?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:23","pubTimestamp":1764343388,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时23分，Biohaven Ltd.股票出现波动，股价大幅拉升5.22%。截至发稿，该股报9.98美元/股，成交量43.0287万股，换手率0.32%，振幅4.07%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.27%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823230897851021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823230897851021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756325.SGD","LU1093756168.USD","BHVN"],"gpt_icon":1},{"id":"1115529931","title":"Biohaven宣布拟进行公众股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1115529931","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115529931?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:22","pubTimestamp":1763572929,"startTime":"0","endTime":"0","summary":"11月12日 - Biohaven Ltd：*BIOHAVEN宣布拟进行公众普通股发行*。Biohaven Ltd：已开始进行价值1.5亿美元的普通股承销公开发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BK4139","BHVN","LU1093756325.SGD"],"gpt_icon":0},{"id":"1183835191","title":"异动解读 | Biohaven宣布1.5亿美元股票发行计划，股价盘前大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183835191","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183835191?lang=zh_cn&edition=full","pubTime":"2025-11-12 18:02","pubTimestamp":1762941755,"startTime":"0","endTime":"0","summary":"生物制药公司Biohaven Pharmaceutical Holding Co Ltd.今日盘前大跌6.46%，引发投资者广泛关注。这一跌幅主要源于公司最新宣布的1.5亿美元股票发行计划。据悉，Biohaven计划发行价值1.5亿美元的新股，用于一般企业用途。值得注意的是，Biohaven目前已发行约1.059亿股，市值约9亿美元。11月5日，美国食品药品监督管理局拒绝批准Biohaven用于治疗脊髓小脑共济失调的实验性药物troriluzole，导致公司股价暴跌40%。投资者将密切关注Biohaven后续的融资进展及其对公司发展的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"1197681055","title":"异动解读 | Biohaven制药夜盘大跌6.10%，宣布1.5亿美元股票发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1197681055","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197681055?lang=zh_cn&edition=full","pubTime":"2025-11-12 09:04","pubTimestamp":1762909490,"startTime":"0","endTime":"0","summary":"生物制药公司Biohaven Pharmaceutical Holding Co Ltd.在夜盘交易中大跌6.10%，引发投资者广泛关注。这一跌幅主要源于公司最新宣布的1.5亿美元股票发行计划。据悉，Biohaven计划发行价值1.5亿美元的新股，用于一般企业用途。值得注意的是，Biohaven目前已发行约1.059亿股，市值约9亿美元。11月5日，美国食品药品监督管理局拒绝批准Biohaven用于治疗脊髓小脑共济失调的实验性药物troriluzole，导致公司股价暴跌40%。投资者将密切关注Biohaven后续的融资进展及其对公司发展的影响。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"1179401425","title":"异动解读 | Biohaven制药盘后暴跌7.51%，宣布1.5亿美元股票发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1179401425","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179401425?lang=zh_cn&edition=full","pubTime":"2025-11-12 06:06","pubTimestamp":1762898786,"startTime":"0","endTime":"0","summary":"周二盘后交易中，Biohaven制药控股有限公司股价大幅下挫7.51%，引发投资者关注。这家生物制药公司刚刚宣布了一项1.5亿美元的股票发行计划，旨在为公司的一般企业用途筹集资金。Biohaven目前已发行约1.059亿股，市值约9亿美元。此次股票发行计划的消息无疑加剧了投资者对公司股权稀释的担忧。Biohaven近期面临重大挫折。尽管如此，在18位分析师中，仍有14位给予Biohaven\"强力买入\"或\"买入\"评级，其余给予\"持有\"评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"2582027188","title":"Biohaven Ltd.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582027188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582027188?lang=zh_cn&edition=full","pubTime":"2025-11-11 02:09","pubTimestamp":1762798153,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日02时09分，Biohaven Ltd.股票出现波动，股价急速下跌5.08%。截至发稿，该股报7.84美元/股，成交量190.374万股，换手率1.80%，振幅7.89%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.53%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110209139760bef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110209139760bef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLTO","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2581080079","title":"新药上市遭FDA拒批，Biohaven(BHVN.US)股价暴跌40%!美银下调评级至“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2581080079","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581080079?lang=zh_cn&edition=full","pubTime":"2025-11-06 10:12","pubTimestamp":1762395154,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Biohaven股价暴跌40.22%，创下52周新低。此前该公司发布消息称，美国食品药品监督管理局对其主要资产Vyglxia的上市申请发出完整回复函，明确拒绝批准该药物。然而，此次CRL的出具令Biohaven措手不及。尽管如此，Biohaven仍表示将继续与FDA保持沟通，推进Vyglxia的监管审批进程，并期待与监管机构会面讨论后续行动。与此同时，Biohaven宣布启动重组计划，暂停或推迟非优先研发管线项目，预计将实现年度研发支出减少约60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"新药上市遭FDA拒批，Biohaven(BHVN.US)股价暴跌40%!美银下调评级至“中性”","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BHVN"],"gpt_icon":0},{"id":"2581593510","title":"Biohaven Ltd.股价重挫34.84% 市值跌3.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581593510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581593510?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:32","pubTimestamp":1762353179,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时32分，Biohaven Ltd.股票出现异动，股价大幅下跌34.84%。截至发稿，该股报9.09美元/股，成交量449.572万股，换手率4.25%，振幅7.74%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.47%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。消息层面，截至22时32分，《TD Cowen维持Biohaven买入评级，下调目标价至15美元》资讯为影响Biohaven Ltd.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223300a48adfb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223300a48adfb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU1093756168.USD","BK4139","BHVN"],"gpt_icon":0},{"id":"1127367064","title":"Biohaven股价在盘前交易中下跌45%，原因是FDA拒绝批准其实验性遗传性脑部疾病药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1127367064","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127367064?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:56","pubTimestamp":1762336571,"startTime":"0","endTime":"0","summary":"Biohaven股价在盘前交易中下跌45%，原因是FDA拒绝批准其实验性遗传性脑部疾病药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756325.SGD","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"1103743180","title":"FDA对Biohaven的Vyglxia（Troriluzole）用于脊髓小脑共济失调的新药申请发出完整回应函","url":"https://stock-news.laohu8.com/highlight/detail?id=1103743180","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103743180?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:07","pubTimestamp":1762304830,"startTime":"0","endTime":"0","summary":"FDA对Biohaven的Vyglxia（Troriluzole）用于脊髓小脑共济失调的新药申请发出完整回应函","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BHVN","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2580787238","title":"Biohaven Ltd.股价重挫10.52% 市值跌1.71亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580787238","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580787238?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:33","pubTimestamp":1762180385,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日22时33分，Biohaven Ltd.股票出现波动，股价快速下跌10.52%。截至发稿，该股报15.39美元/股，成交量95.4673万股，换手率0.90%，振幅11.16%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.29%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103223305a6de2616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103223305a6de2616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BHVN","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2577294343","title":"Biohaven Ltd.盘中异动 早盘快速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577294343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577294343?lang=zh_cn&edition=full","pubTime":"2025-10-22 23:29","pubTimestamp":1761146953,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日23时29分，Biohaven Ltd.股票出现异动，股价快速下跌5.13%。截至发稿，该股报16.82美元/股，成交量69.4345万股，换手率0.66%，振幅5.30%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.50%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223291394d80300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102223291394d80300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2574167888","title":"Biohaven Ltd.盘中异动 早盘快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574167888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574167888?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:02","pubTimestamp":1760018525,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日22时02分，Biohaven Ltd.股票出现异动，股价急速上涨5.22%。截至发稿，该股报16.14美元/股，成交量21.4238万股，换手率0.20%，振幅4.95%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.31%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009220205a4586849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009220205a4586849&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4139","BHVN","LU1093756168.USD"],"gpt_icon":0},{"id":"2568291033","title":"Biohaven Ltd.盘中异动 下午盘股价大跌5.06%报14.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568291033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568291033?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:13","pubTimestamp":1758305615,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时13分，Biohaven Ltd.股票出现波动，股价急速下挫5.06%。截至发稿，该股报14.74美元/股，成交量82.3947万股，换手率0.78%，振幅5.77%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.47%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920021336a4378781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920021336a4378781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BHVN","LU1093756168.USD","BK4139"],"gpt_icon":0},{"id":"2568542658","title":"花旗予Biohaven(BHVN.US)“买入”评级 看好其核心药物曲鲁唑获FDA批准潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2568542658","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568542658?lang=zh_cn&edition=full","pubTime":"2025-09-18 14:22","pubTimestamp":1758176529,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Biohaven核心驱动因素在于主要资产曲鲁唑有望潜在获得FDA批准——该药物目前正处于FDA审查阶段，花旗银行给予该股买入评级并设定每股28美元目标价。Semenkow在分析中强调，对曲鲁唑的临床数据、监管先例及Oberland Capital在监管决策前投资的决策逻辑进行综合研判后，认为该药物获得批准的可能性超过五成。若曲鲁唑最终获批，预计Biohaven股价将迎来显著上涨空间。周三，Biohaven收涨8.97%，报14.7美元，截至发稿，该股盘后续涨4.42%，报15.35美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BHVN"],"gpt_icon":0},{"id":"2561474544","title":"FDA取消核心药物咨询委员会会议Biohaven(BHVN.US)盘前大涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561474544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561474544?lang=zh_cn&edition=full","pubTime":"2025-08-22 20:31","pubTimestamp":1755865917,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，此前，美国食品药品监督管理局取消了原计划就Biohaven核心药物troriluzole上市申请召开的咨询委员会会议，该股美股周五盘前大幅上涨，截至发稿，该股上涨12.3%。5月，FDA神经科学办公室延长了审评周期，以评估该公司为回应机构要求而提交的补充材料，并决定召开咨询委员会会议讨论该新药申请。该公司仍预计，美国食品药品监督管理局将在2025年第四季度对其递交的新药上市申请做出审批决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"1177190493","title":"Biohaven股价盘前上涨11.2% 美国FDA称遗传疾病药物无需咨询委员会审议","url":"https://stock-news.laohu8.com/highlight/detail?id=1177190493","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177190493?lang=zh_cn&edition=full","pubTime":"2025-08-22 20:21","pubTimestamp":1755865301,"startTime":"0","endTime":"0","summary":"Biohaven股价盘前上涨11.2%，此前美国FDA表示其遗传疾病药物无需咨询委员会审议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2558656846","title":"Biohaven Ltd.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558656846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558656846?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:32","pubTimestamp":1754919128,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时32分，Biohaven Ltd.股票出现异动，股价大幅跳水5.36%。截至发稿，该股报13.95美元/股，成交量12.6364万股，换手率0.12%，振幅2.41%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.46%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112132089740e38e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112132089740e38e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU1093756168.USD","BK4139","BHVN"],"gpt_icon":0},{"id":"2557857353","title":"Biohaven Ltd.盘中异动 急速下挫5.06%报14.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557857353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557857353?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:55","pubTimestamp":1754664928,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时55分，Biohaven Ltd.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报14.46美元/股，成交量28.4339万股，换手率0.28%，振幅5.15%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.86%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808225528a6db40cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808225528a6db40cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU1093756168.USD","BK4139","BHVN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":-0.0481},{"period":"1month","weight":0.0836},{"period":"3month","weight":-0.2358},{"period":"6month","weight":-0.2877},{"period":"1year","weight":-0.7095},{"period":"ytd","weight":-0.7189}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biohaven Ltd.是一家于2022年5月2日在英属维尔京群岛注册成立的英属维尔京群岛商业有限公司。该公司是一家生物制药公司，专注于关键治疗领域改变生命的治疗方法的发现、开发和商业化，包括免疫学、神经科学和肿瘤学。该公司正在推进创新疗法组合，利用经过验证的药物开发经验和多个专有药物开发平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.074852},{"month":2,"riseRate":0.25,"avgChangeRate":-0.026088},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102404},{"month":4,"riseRate":0.5,"avgChangeRate":0.0146},{"month":5,"riseRate":0.625,"avgChangeRate":0.144142},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056007},{"month":7,"riseRate":0.555556,"avgChangeRate":0.010799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043364},{"month":9,"riseRate":0.777778,"avgChangeRate":0.09598},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.046232}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}